This Web page located on the National Institute of Justice's Web site, contains a summary of the panel discussion on medication-assisted treatment for heroin and other opioid abusing offenders held in Washington, DC, on October 3, 2007. The primary objective of the meeting was to examine the use of opioids and treatment options for offenders who are incarcerated or under supervision in the community. Previous research has found that while counseling and other non-medication treatment therapies can be successful, the use of medications such as methadone and buprenorphine can also improve outcomes for offenders. Several issues that could affect the outcomes for offenders were raised during the discussion. These included the treatment philosophy of complete abstinence (clean and sober), the appropriateness of short-term (buprenorphine) vs. long-term (methadone) regimens, heroin (including injection drug) vs. other opioid (prescription drug) abusers, and nonclinical problems of compliance and improper use (boosting with alcohol and other drugs).
Downloads
Similar Publications
- QCM-based screening of acrylate polymers for NPPA pre-concentration to enhance vapor detection of fentanyl
- Recreational Cannabis Legalization in Washington State: Residents' Opinions and Perceptions of Effects Five Years after Implementation
- “Do It Yourself” Synthetic Cannabinoid Receptor Agonist Precursors as a Ban-Evading Strategy: Comparison of the Pharmacological Characteristics of Precursors and Their Final Products